GlassScriptPhysician profile
Geraldine Best
NPI 1285967778
$1,359.08
in general payments reported to CMS, 2019-2025
16 companies · $67.40 in 2025
The $67.40 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.16 · 2022: $14.50 · 2023: $587 · 2024: $646 · 2025: $67.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $232.46 | 2023-2024 | |
| Corium, LLC | $221.85 | 2023-2024 | Azstarys, Azstarys |
| Teva Pharmaceuticals USA, INC. | $212.37 | 2023-2024 | Uzedy, Austedo Xr, Austedo |
| Alkermes, INC. | $158.77 | 2021-2024 | Lybalvi, Aristada |
| Axsome Therapeutics, INC. | $145.78 | 2024 | Auvelity, Sunosi |
| Neurocrine Biosciences, INC. | $97.68 | 2023-2024 | Ingrezza |
| Lundbeck LLC | $61.00 | 2022-2024 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $44.66 | 2024-2025 | Cobenfy |
| Takeda Pharmaceuticals U.S.A., INC. | $37.02 | 2024 | Trintellix |
| Vanda Pharmaceuticals INC. | $33.43 | 2024-2025 | Fanapt |
| Indivior INC. | $33.07 | 2024 | Perseris |
| Cycle Pharmaceuticals INC | $19.40 | 2025 | Phyrago |
| Idorsia Pharmaceuticals US INC | $16.53 | 2023 | Quviviq |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.97 | 2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $15.00 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $14.09 | 2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geraldine Best listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.